ALLISON BAILEY: Open Payments
NPI 1053908970 · DANVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$840 in 40 payments from 11 companies in 2025. Trend: 2023 $460 · 2024 $683 · 2025 $840
Food & beverage: $840
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $213 |
| ABBVIE INC. | 17 | $201 |
| Novo Nordisk Inc | 2 | $130 |
| Lilly USA, LLC | 4 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
| PFIZER INC. | 2 | $49 |
| Exact Sciences Corporation | 2 | $44 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: AIRSUPRA, Ozempic, QULIPTA, MOUNJARO, Kerendia, VRAYLAR, The Cologuard Plus Collection Kit, NURTEC ODT.
Industry payments across VA — which companies pay providers there.
